Is Agile Therapeutics, Inc. (AGRX) a Buy, Sell, or Hold?
NASDAQ : AGRX
Agile Therapeutics, Inc. — Institutional Ownership
$1.51 USD
$0.05 (3.42%)
- Volume
- 119.29K
- Average Volume
- 154.55K
- Market Capitalization
- $10.43M
- P/E Ratio
- -0.23
- Dividend Yield
- 0.00%
- Price Target
- $1.00
- Year High
- $2.63
- Year Low
- $0.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.46
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2024-07-09 | Beryl Capital Management LLC | 680K | 11.00% |
| 2024-07-09 | David A. Witkin | 680K | 11.00% |
| 2024-07-09 | Beryl Capital Partners II LP | 579.53K | 11.00% |
| 2024-07-09 | Beryl Capital Management LP | 680K | 11.00% |
| 2024-07-02 | ROGER M. KLEIN | 618K | 9.00% |
| 2022-07-12 | Lind Global Fund II LP | 3.25M | 9.90% |
| 2022-07-12 | Lind Global Partners II LLC | 3.25M | 9.90% |
| 2022-07-12 | Jeff Easton | 3.25M | 9.90% |
| 2022-07-11 | Intracoastal Capital LLC | 3.43M | 9.99% |
| 2022-07-11 | Mitchell P. Kopin | 3.43M | 9.99% |
| 2022-07-11 | Daniel B. Asher | 3.43M | 9.99% |
| 2022-02-14 | Perceptive Advisors LLC | 21.29M | 17.50% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 4.49M | 3.70% |
| 2021-07-12 | (1) BlackRock, Inc. | 1.31M | 1.50% |
| 2021-02-16 | Perceptive Advisors LLC | 15.92M | 18.20% |
| 2021-02-16 | Joseph Edelman | 15.92M | 18.20% |
| 2021-02-16 | Perceptive Life Sciences Master Fund, Ltd. | 15.92M | 18.20% |
| 2021-02-10 | 13-3127734 | - | 0.00% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 4.37M | 5.00% |
| 2021-02-10 | 26-0385758 | - | 0.00% |
| 2021-02-02 | (1) BlackRock, Inc. | 5.12M | 5.90% |
| 2020-02-13 | Vivo Capital VIII, LLC | 189.25K | 0.30% |
| 2020-02-13 | 26-0385758 | 3.27M | 5.51% |
| 2020-02-13 | 13-3127734 | 3.27M | 5.51% |
| 2019-11-18 | Joseph Edelman | 11.92M | 18.50% |
| 2019-11-18 | Perceptive Life Sciences Master Fund, Ltd. | 11.92M | 18.50% |
| 2019-11-18 | Perceptive Advisors LLC | 11.92M | 18.50% |
| 2019-10-30 | Joseph Edelman | 6.91M | 11.70% |
| 2019-10-30 | Perceptive Advisors LLC | 6.91M | 11.70% |
| 2019-10-30 | Perceptive Life Sciences Master Fund, Ltd. | 6.91M | 11.70% |
| 2019-03-06 | 10 | 8.43M | 19.49% |
| 2019-03-06 | 10 | 8.43M | 19.49% |
| 2019-03-06 | 10 | 8.43M | 19.49% |
| 2019-02-14 | 10 | - | 0.00% |
| 2019-02-14 | 10 | - | 0.00% |
| 2019-02-14 | 10 | - | 0.00% |
| 2019-02-12 | 26-0385758 | 1.94M | 5.65% |
| 2019-02-12 | 13-3127734 | 1.94M | 5.65% |
| 2018-09-25 | CARE CAPITAL INVESTMENTS III LP | - | 0.00% |
| 2018-09-25 | CARE CAPITAL III LLC | - | 0.00% |
| 2018-09-25 | CARE CAPITAL OFFSHORE INVESTMENTS III LP | - | 0.00% |
| 2018-05-22 | Bruce S. Kovner | 671.82K | 2.00% |
| 2018-05-22 | Caxton Corporation | 671.82K | 2.00% |
| 2018-03-28 | 10 | 3.53M | 10.30% |
| 2018-03-28 | 10 | 3.53M | 10.30% |
| 2018-03-28 | 10 | 3.53M | 10.30% |
| 2018-02-14 | Bruce S. Kovner | 1.82M | 5.33% |
| 2018-02-14 | Caxton Corporation | 1.82M | 5.33% |
| 2018-02-13 | Adage Capital Advisors, L.L.C. | - | 0.00% |
| 2018-02-13 | Phillip Gross | - | 0.00% |
| 2018-02-13 | Adage Capital Partners GP, L.L.C. | - | 0.00% |
| 2018-02-13 | Adage Capital Partners, L.P. | - | 0.00% |
| 2018-02-13 | Robert Atchinson | - | 0.00% |
| 2018-02-05 | The Vanguard Group | 9.61M | 5.93% |
| 2018-02-01 | Steven Elms | 1.85M | 3.80% |
| 2018-02-01 | Dennis Purcell | 1.86M | 3.80% |
| 2018-02-01 | Aisling Capital Partners III LLC | 1.3M | 3.80% |
| 2018-02-01 | Aisling Capital Partners III, LP | 1.3M | 3.80% |
| 2018-02-01 | Aisling Capital III, LP | 1.3M | 3.80% |
| 2018-02-01 | Andrew Schiff | 1.85M | 3.80% |
| 2018-01-09 | 10 | 3.38M | 9.90% |
| 2018-01-09 | 10 | 3.38M | 9.90% |
| 2018-01-09 | 10 | 3.38M | 9.90% |
| 2017-08-18 | Caxton Corporation | 1.82M | 5.30% |
| 2017-08-18 | Bruce S. Kovner | 1.82M | 5.30% |
| 2017-08-04 | Caxton Corporation | 1.65M | 4.80% |
| 2017-02-13 | Vivo Capital VIII, LLC | 1.51M | 5.26% |
| 2017-02-09 | Adage Capital Partners, L.P. | 1.7M | 5.91% |
| 2017-02-09 | Adage Capital Partners GP, L.L.C. | 1.7M | 5.91% |
| 2017-02-09 | Phillip Gross | 1.7M | 5.91% |
| 2017-02-09 | Robert Atchinson | 1.7M | 5.91% |
| 2017-02-09 | Adage Capital Advisors, L.L.C. | 1.7M | 5.91% |
| 2017-02-06 | CDK Associates, L.L.C. | 1.98M | 6.90% |
| 2017-02-06 | Caxton Corporation | 2.12M | 7.40% |
| 2017-02-06 | Bruce S. Kovner | 2.12M | 7.40% |
| 2016-10-27 | Aisling Capital Partners III LLC | 1.85M | 6.40% |
| 2016-10-27 | Steven Elms | 1.85M | 6.40% |
| 2016-10-27 | Andrew Schiff | 1.85M | 6.40% |
| 2016-10-27 | Aisling Capital Partners III, LP | 1.85M | 6.40% |
| 2016-10-27 | Dennis Purcell | 1.86M | 6.40% |
| 2016-10-27 | Aisling Capital III, LP | 1.85M | 6.40% |
| 2016-04-29 | Caxton Corporation | 1.56M | 5.40% |
| 2016-04-29 | Bruce S. Kovner | 1.56M | 5.40% |
| 2016-04-29 | CDK Associates, L.L.C. | 1.5M | 5.20% |
| 2016-02-16 | Peter Kolchinsky | - | 0.00% |
| 2016-02-16 | Adage Capital Advisors, L.L.C. | 1.4M | 6.28% |
| 2016-02-16 | Phillip Gross | 1.4M | 6.28% |
| 2016-02-16 | Robert Atchinson | 1.4M | 6.28% |
| 2016-02-16 | Adage Capital Partners GP, L.L.C. | 1.4M | 6.28% |
| 2016-02-16 | Adage Capital Partners, L.P. | 1.4M | 6.28% |
| 2016-02-16 | RA Capital Management, LLC | - | 0.00% |
| 2016-02-16 | RA Capital Healthcare Fund, L.P. | - | 0.00% |
| 2016-02-01 | 9 | 1.7M | 7.60% |
| 2016-01-29 | Jay Moorin | 5.06M | 18.20% |
| 2016-01-29 | 20-0992451 | 3.1M | 11.20% |
| 2016-01-29 | Alain Schreiber | 5.06M | 18.20% |
| 2016-01-29 | 20-5935001 | 1.96M | 7.00% |
| 2016-01-29 | 20-5934968 | 1.96M | 7.00% |
| 2016-01-29 | 20-0992411 | 3.1M | 11.20% |
| 2015-02-17 | Investor AB | 3.51M | 18.90% |
| 2015-01-30 | Peter Kolchinsky | 1.46M | 6.60% |
| 2015-01-30 | RA Capital Healthcare Fund, L.P. | 1.18M | 5.40% |
| 2015-01-30 | RA Capital Management, LLC | 1.46M | 6.60% |
| 2015-01-27 | Aisling Capital III, LP | 2.98M | 13.60% |
| 2015-01-27 | Aisling Capital Partners III, LP | 2.98M | 13.60% |
| 2015-01-27 | Aisling Capital Partners III LLC | 2.98M | 13.60% |
| 2015-01-27 | Steven Elms | 2.98M | 13.60% |
| 2015-01-27 | Dennis Purcell | 2.98M | 13.60% |
| 2015-01-27 | Andrew Schiff | 2.98M | 13.60% |
| 2015-01-23 | ProQuest Investments III, L.P. | 3.1M | 15.50% |
| 2015-01-23 | ProQuest Investments IV, L.P. | 1.57M | 7.80% |
| 2015-01-23 | ProQuest Associates IV LLC 2 | 1.57M | 7.80% |
| 2015-01-23 | Jay Moorin | 4.69M | 23.40% |
| 2015-01-23 | Alain Schreiber | 4.69M | 23.40% |
| 2015-01-23 | ProQuest Associates III LLC | 3.1M | 15.50% |
| 2014-06-03 | 13G | 2.96M | 11.00% |
| 2014-06-03 | 13G | 3.01M | 11.00% |
| 2014-06-03 | 13G | 49446.0 | 11.00% |
| 2014-06-02 | Jay Moorin | 3.86M | 20.70% |
| 2014-06-02 | ProQuest Investments IV, L.P. | 1.18M | 6.30% |
| 2014-06-02 | ProQuest Associates IV LLC 2 | 1.18M | 6.30% |
| 2014-06-02 | ProQuest Associates III LLC | 2.68M | 14.40% |
| 2014-06-02 | ProQuest Investments III, L.P. | 2.68M | 14.40% |
| 2014-06-02 | Alain Schreiber | 3.86M | 20.70% |
| 2014-05-30 | Aisling Capital III, LP | 2.17M | 11.70% |
| 2014-05-30 | Phillip Gross | 1.2M | 6.45% |
| 2014-05-30 | Andrew Schiff | 2.17M | 11.70% |
| 2014-05-30 | Dennis Purcell | 2.17M | 11.70% |
| 2014-05-30 | Steven Elms | 2.17M | 11.70% |
| 2014-05-30 | Aisling Capital Partners III LLC | 2.17M | 11.70% |
| 2014-05-30 | Robert Atchinson | 1.2M | 6.45% |
| 2014-05-30 | Aisling Capital Partners III, LP | 2.17M | 11.70% |
| 2014-05-30 | Adage Capital Partners, L.P. | 1.2M | 6.45% |
| 2014-05-30 | Adage Capital Partners GP, L.L.C. | 1.2M | 6.45% |
| 2014-05-30 | Adage Capital Advisors, L.L.C. | 1.2M | 6.45% |
AGRX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $1.95 | 2.16M | $4.21M | $2.56M | $2.17M | $3.82M |
| 2022-12-31 | $11.35 | 432.22K | $4.91M | $5.25M | $2.21M | $1.87M |
| 2021-12-31 | $9.76 | 1213 | $11838.88 | $19.14M | $17.97M | -$1.16M |
| 2020-12-31 | $57.40 | 42341 | $2.43M | $14.46M | $16.52M | $4.49M |
| 2019-12-31 | $50.00 | 24716 | $1.24M | $34.48M | $172K | -$33.07M |
| 2018-12-31 | $11.52 | 17157 | $197.65K | $7.85M | -$ | -$7.65M |
| 2017-12-31 | $53.80 | 15470 | $832.29K | $35.95M | $10.61M | -$24.51M |
| 2016-12-31 | $11.40 | 14136 | $161.15K | $48.75M | $16M | -$32.59M |
| 2015-12-31 | $19.52 | 11008 | $214.88K | $34.4M | $15.52M | -$18.66M |
| 2014-12-31 | $12.28 | 5697 | $69959.16 | $40.18M | $14.83M | -$25.28M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-06-30 | $1.42 | 6.86M | $9.7M | $2.85M | $289K | $7.14M |
| 2024-03-31 | $0.27 | 4.63M | $1.25M | $2.62M | $378K | -$986.39K |
| 2023-12-31 | $1.95 | 2.96M | $5.78M | $2.56M | $2.17M | $5.39M |
| 2023-09-30 | $2.40 | 2.95M | $7.08M | $2.87M | $2.87M | $7.08M |
| 2023-06-30 | $2.95 | 1.77M | $5.22M | $2.78M | $2.69M | $5.13M |
| 2023-03-31 | $11.20 | 912.04K | $10.21M | $4.43M | $2.55M | $8.33M |
| 2022-12-31 | $11.35 | 824.65K | $9.36M | $5.25M | $2.21M | $6.32M |
| 2022-09-30 | $14.85 | 739.96K | $10.99M | $6.14M | $2.42M | $7.27M |
| 2022-06-30 | $58.25 | 90204 | $5.25M | $13.03M | $13.5M | $5.73M |
| 2022-03-31 | $42.00 | 62304 | $2.62M | $3.74M | $13.42M | $12.3M |
| 2021-12-31 | $9.76 | 58363 | $569.62K | $19.14M | $17.97M | -$606.38K |
| 2021-09-30 | $19.22 | 46588 | $895.42K | $14.74M | $16.47M | $2.63M |